GlobalData's clinical trial report, “Memory Impairment Global Clinical Trials Review, Q1, 2011 provides data on the Memory Impairment clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Memory Impairment . It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Memory Impairment .This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. 

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. 

Scope

• Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status and trial success rate
• Review of key discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

• Understand the dynamics of a particular indication as a whole
• Examine the performance of the trials in terms of their status, recruitment, success rates and others
• Obtain discontinued trial information for trials across the globe
• Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Memory Impairment 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials by Country 7
Top Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Clinical Trials by Phase 11
In Progress Trials by Phase 12
Clinical Trials by Trial Status 13
Subjects Recruited Over a Period of Time 14
Prominent Sponsors 15
Top Companies Participating in Memory Impairment Therapeutics Clinical Trials 17
Prominent Drug Comparison 19
Clinical Trial Profiles 20
Clinical Trial Overview of Top Companies 20
UCB S.A. 20
Clinical Trial Overview of UCB S.A. 20
Accera, Inc. 21
Clinical Trial Overview of Accera, Inc. 21
Eisai Inc. 22
Clinical Trial Overview of Eisai Inc. 22
Martek Biosciences Corporation 23
Clinical Trial Overview of Martek Biosciences Corporation 23
Intermountain Healthcare, Inc. 24
Clinical Trial Overview of Intermountain Healthcare, Inc. 24
Neuronetrix, Inc. 25
Clinical Trial Overview of Neuronetrix, Inc. 25
AstraZeneca PLC 26
Clinical Trial Overview of AstraZeneca PLC 26
Kinamed Incorporated 27
Clinical Trial Overview of Kinamed Incorporated 27
Clinical Trial Overview of Top Universities / Institutes / Hospitals 28
The University of Texas at Austin 28
Clinical Trial Overview of The University of Texas at Austin 28
National Institute of Mental Health (NIMH) 29
Clinical Trial Overview of National Institute of Mental Health (NIMH) 29
Rush University Medical Center 30
Clinical Trial Overview of Rush University Medical Center 30
University of Washington 31
Clinical Trial Overview of University of Washington 31
Ullevaal University Hospital 32
Clinical Trial Overview of Ullevaal University Hospital 32
University Hospital, Grenoble 33
Clinical Trial Overview of University Hospital, Grenoble 33
Maastricht University Medical Center 34
Clinical Trial Overview of Maastricht University Medical Center 34

Appendix 35
Abbreviations 35
Definitions 35
Research Methodology 36
Secondary Research 36
About GlobalData 37
Contact Us 37
Disclaimer 37
Source 37

List of Tables

Memory Impairment Therapeutics Market, Global, Clinical Trials by Zone, 2011* 6
Memory Impairment Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 7
Memory Impairment Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 8
Memory Impairment Therapeutics Clinical Trials, Europe, Top Countries, 2011* 9
Memory Impairment Therapeutics Clinical Trials, North America, Top Countries, 2011* 10
Memory Impairment Therapeutics Market, Global, Clinical Trials by Phase, 2011* 11
Memory Impairment Therapeutics Market, Global, Clinical Trials in Progress by Phase 2011* 12
Memory Impairment Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 13
Memory Impairment Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 14
Memory Impairment Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 16
Memory Impairment Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 18
Memory Impairment Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011** 19
Memory Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2011* 20
Memory Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Accera, Inc., 2011* 21
Memory Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2011* 22
Memory Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Martek Biosciences Corporation, 2011* 23
Memory Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Intermountain Healthcare, Inc., 2011* 24
Memory Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Neuronetrix, Inc., 2011* 25
Memory Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2011* 26
Memory Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Kinamed Incorporated, 2011* 27
Memory Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas at Austin, 2011* 28
Memory Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health (NIMH), 2011* 29
Memory Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Rush University Medical Center, 2011* 30
Memory Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2011* 31
Memory Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Ullevaal University Hospital, 2011* 32
Memory Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Grenoble, 2011* 33
Memory Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2011* 34

List of Figures

Memory Impairment Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 6
Memory Impairment Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 7
Memory Impairment Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 8
Memory Impairment Therapeutics Clinical Trials, Europe, Top Countries (%), 2011* 9
Memory Impairment Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 11
Memory Impairment Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2011* 12
Memory Impairment Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 13
Memory Impairment Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 14
Memory Impairment Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 15
Memory Impairment Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 17
Memory Impairment Syndrome Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011** 19
GlobalData Methodology 36